Mid-Cap Pharma: Wockhardt jump starts sales 42%

The run of luck for the company has changed finally after restructuring and FCCB woes were mostly disposed off as the medicine major brought back 43% jump in sales to INR14.3B and has doubled profits from INR 1.94 Bln odd to INR3.8B, despite RM casts having jumped from 24B to 41B


Comments are closed.

Up ↑

%d bloggers like this: